ANTONIO IGNACIO
FERNÁNDEZ ORTIZ
Profesor asociado de Ciencias de la Salud
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (48)
2024
-
Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study
Circulation Research, Vol. 134, Núm. 4, pp. 411-424
-
Unidirectional association of clonal hematopoiesis with atherosclerosis development
Nature Medicine
2023
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083
-
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis
Cardiovascular Diabetology, Vol. 22, Núm. 1
-
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498
-
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
European heart journal, Vol. 44, Núm. 29, pp. 2698-2709
2022
-
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828
-
Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial
European heart journal, Vol. 43, Núm. 38, pp. 3732-3745
-
New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume
JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135
-
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
eBioMedicine, Vol. 76
2021
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8
Journal of the American College of Cardiology, Vol. 78, Núm. 2, pp. 156-179
-
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study
Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 888-898
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
Association Between Body Size Phenotypes and Subclinical Atherosclerosis
The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 12
-
Association Between Left Ventricular Noncompaction and Vigorous Physical Activity
Journal of the American College of Cardiology, Vol. 76, Núm. 15, pp. 1723-1733
-
Complement C5 Protein as a Marker of Subclinical Atherosclerosis
Journal of the American College of Cardiology, Vol. 75, Núm. 16, pp. 1926-1941
-
Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals
Journal of the American College of Cardiology, Vol. 76, Núm. 14, pp. 1674-1685
-
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
Journal of the American College of Cardiology, Vol. 75, Núm. 14, pp. 1617-1627